rheumatoid-arthritis

Documents about rheumatoid-arthritis

• A Drug Interaction Study Between Tocilizumab, Methotrexate and Simvastatin on Patients With Rheumatoid Arthritis.#832819ClinicalTrials.gov
• Proprotein Convertase Subtilisin Kexin 9 in Rheumatoid Arthritis#834435ClinicalTrials.gov
• A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis#842632ClinicalTrials.gov
• A Study of CH-4051 in Patients With Rheumatoid Arthritis (RA)#843735ClinicalTrials.gov
• Special Investigation of Humira® (Adalimumab) on Long-term Treatment in Patients With Rheumatoid Arthritis#856606ClinicalTrials.gov
• A Study of the Efficacy and Safety of Tocilizumab in Adults With Rheumatoid Arthritis.#871249ClinicalTrials.gov
• A Study to Observe Characteristics of Rheumatoid Arthritis in Patients Using Infliximab (Study P04250)#872324ClinicalTrials.gov
• First Human Dose Trial of NNC0215-0384 in Subjects With Rheumatoid Arthritis#877277ClinicalTrials.gov
• A Non-Interventional Study of RoActemra/Actemra in Patients With Moderate to Severe Rheumatoid Arthritis#879690ClinicalTrials.gov
• Exercise Perceptions and Preferences Among Rheumatoid Arthritis Patients#881046ClinicalTrials.gov
• Interstitial Lung Disease in Early Rheumatoid Arthritis#881184ClinicalTrials.gov
• NFKB1 and IKK Epsilon in Rheumatoid Arthritis#883343ClinicalTrials.gov
• The Effects of Cardiac Rehabilitation Programme in Hypertensive Rheumatoid Arthritis Patients#901509ClinicalTrials.gov
• Iyengar Yoga for Young People With Rheumatoid Arthritis#911300ClinicalTrials.gov
• A Phase 3 Study of NI-071 in Patients With Rheumatoid Arthritis#912551ClinicalTrials.gov
• Reducing Sedentary Time in Rheumatoid Arthritis: The Take a STAND for Health Study#915662ClinicalTrials.gov
• Drug Management of Rheumatoid Arthritis in Covid-19 Context : Impact on Therapeutic De-escalation#980507ClinicalTrials.gov
• Clinically Important Changes in Rheumatoid Arthritis#825705ClinicalTrials.gov
• Genetic and Immune Studies of Rheumatoid Arthritis and Related Conditions#847776ClinicalTrials.gov
• The Safety and Efficacy of Chicken Type II Collagen on Uveitis Associated With Juvenile Rheumatoid Arthritis#876237ClinicalTrials.gov
• A Study of Oral Upadacitinib Tablets to Assess Treatment Patterns, Achievement of Treatment Targets and Maintenance of Response in Adult Participants With Moderate to Severe Rheumatoid Arthritis#897428ClinicalTrials.gov
• Clinical and Dermoscopic Comparison of Rheumatoid Arthritis, Ankylosing Spondylitis and Psoriasis Patients' Nails#873007ClinicalTrials.gov
• To Evaluate the Blood Levels and Safety of IV and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis Using Methotrexate#886507ClinicalTrials.gov
• An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Adults With Rheumatoid Arthritis#67705ClinicalTrials.gov
• The Immunogenicity and Safety of Zostavax® and Shingrix® in Rheumatoid Arthritis Patients Using Abatacept#290831ClinicalTrials.gov
• Co-Administration Of Methotrexate And CP-690,550#807154ClinicalTrials.gov
• An Observational Study on RoActemra/Actemra (Tocilizumab) in Clinical Practice in Patients With Rheumatoid Arthritis (TRUST)#824831ClinicalTrials.gov
• Effects of SARAH Protocol in Women With Rheumatoid Arthritis#825630ClinicalTrials.gov
• Gene Expression Profiling in PBMCs as a Tool for Prediction of Infliximab Responsiveness in Rheumatoid Arthritis#826337ClinicalTrials.gov
• Effectiveness and Safety of Adalimumab in Rheumatoid Arthritis Patients in Routine Clinical Practice#838422ClinicalTrials.gov
• To Evaluate the Immunogenicity and Safety of Sarilumab Administered as Monotherapy in Patients With Rheumatoid Arthritis (RA)#840818ClinicalTrials.gov
• T-cell Subsets in Rheumatoid Arthritis Patients on Long-term Anti-TNF or IL6-receptor-blocker Therapy#841481ClinicalTrials.gov
• Effect of SAR153191 (REGN88) With Methotrexate in Patients With Active Rheumatoid Arthritis Who Failed TNF-α Blockers#847130ClinicalTrials.gov
• Telitacicept for the Treatment of Refractory RA#850539ClinicalTrials.gov
• Manual Lymphatic Drainage for Rheumatoid Arthritis#855336ClinicalTrials.gov
• Safety and Effectiveness of Infliximab in Slovakia When Used for Rheumatoid Arthritis (Study P04741)(COMPLETED)#862932ClinicalTrials.gov
• Efficacy and Safety Study of TAS5315 Compared With Placebo in Participants With Rheumatoid Arthritis.#873132ClinicalTrials.gov
• A Rheumatoid Arthritis (RA) Study Treating Signs and Symptoms of RA in People With RA & Receiving Methotrexate#878378ClinicalTrials.gov
• A Retrospective Observational Study on the Use of Biologics in Monotherapy in Patients With Rheumatoid Arthritis#887288ClinicalTrials.gov
• A Study Comparing LBAL to Humira® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy#888528ClinicalTrials.gov
• Phase II Trial of VDJ001 in Patients With Moderate-to-severe Active Rheumatoid Arthritis#891796ClinicalTrials.gov
• Multiple Dose Study of UCB4940 as add-on to Certolizumab Pegol in Subjects With Rheumatoid Arthritis#894340ClinicalTrials.gov
• The Survey of Satisfaction in Chinese Rheumatologists and Patients With Rheumatoid Arthritis#897416ClinicalTrials.gov
• Dose-Escalating Multiple Dose Study of PD-0360324 in Combination With Methotrexate in Patients With Rheumatoid Arthritis#910748ClinicalTrials.gov
• A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis (MONACO)#912558ClinicalTrials.gov
• Interleukin-6 Inhibitors and Drug-drug Interactions in Patients With Rheumatoid Arthritis#916674ClinicalTrials.gov
• Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept#991886ClinicalTrials.gov
• A Study of Two Doses of MRC375 in Moderate to Severe Rheumatoid Arthritis Patients#1010623ClinicalTrials.gov
• Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate#855056ClinicalTrials.gov
• A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 6 Weeks in Adults With Moderately to Severely Active Rheumatoid Arthritis and an Inadequate Response to Methotrexate#844252ClinicalTrials.gov